Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 19, 2025 09:46 ET | Source: Research and Markets

Lung Transplant Rejection Research Report 2025-2035: TFF Pharmaceuticals and Astellas Lead by Investing Heavily in R&D to Improve Existing Immunosuppressive Therapies, and Develop New Biologics

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Lung Transplant Rejection Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" report has been...
November 19, 2025 08:30 ET | Source: Precise Bio Inc.

Precise Bio Achieves World’s First 3D-Bio-Printed Corneal Implant

Precise Bio Achieves World’s First 3D-Bio-Printed Corneal Implant
November 18, 2025 12:12 ET | Source: Research and Markets

$24.13 Bn Organ Transplant Markets - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Dublin, Nov. 18, 2025 (GLOBE NEWSWIRE) -- The "Organ Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ...
November 14, 2025 17:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results
November 06, 2025 18:30 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology’s Kidney Week 2025 Annual Meeting

Eledon Presents Phase 2 BESTOW Trial Results for Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the ASN Kidney Week
November 05, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference

Eledon Pharmaceuticals to Present at Guggenheim Second Annual Healthcare Innovation Conference
October 17, 2025 07:00 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting

Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at Kidney Week
September 24, 2025 16:05 ET | Source: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
September 18, 2025 05:36 ET | Source: Research and Markets

Europe Flow Cytometry Research Report 2025: Market to Surpass $2 Billion by 2035 - Expanding Use in Drug Discovery, Translational Research, and Clinical Trials

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Europe Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry...
September 03, 2025 04:33 ET | Source: Research and Markets

Flow Cytometry Market Insights, Growth Outlook and Competitive Intelligence 2025-2033 Featuring BD, Danaher, Thermo Fisher Scientific, Agilent Technologies, and Sony Among Others

Dublin, Sept. 03, 2025 (GLOBE NEWSWIRE) -- The "Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits),...